Aktuellt
SENASTE
XVIVO’s financial target is to reach an EBIT margin of 20% and EBITDA margins of 30%. XVIVO is confident about the Abdominal business potential, and the objective is to deliver growth that brings the Abdominal business level with the Thoracic business.
